NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits have been filed on behalf of Carvana Co. (NYSE: CVNA) shareholders. , Kiromic BioPharma, Inc. (NASDAQ: KRBP), LifeStance Health Group, Inc. (NASDAQ: LFST) and MINISO Group Holding Limited (NYSE: MNSO). Shareholders have until the deadlines below to petition the court to appear as lead plaintiffs. For more information on each case, see the link provided.

Carvana Co (NYSE:CVNA)

Class Period: May 6, 2020 – June 24, 2022

Lead Plaintiff Deadline: October 3, 2022

On June 24, 2022, Barron’s published an article entitled “Carvana Attempted to Disrupt Auto Sales. It Delivered Undriveable Cars”, which states, among other things: “[i]In its rush to grab market share from competitors, Carvana was selling cars faster than it could let them to their new owners” and “at one point it formed an ad hoc entity known as the ‘Undriveable Cars Task Force.’ is”; “[i]In other cases…Carvana sold cars before it had ownership of the vehicles, an act illegal in many states in which the company operates”; and “US government regulators have complied [Carvana] to suspensions or increased surveillance of registration delays and its practice of issuing multiple temporary license plates from states where it has dealer licenses rather than immediately issuing permanent ones. For example, the article states: “Pennsylvania officials suspended [Carvana’s] Licensed to issue temporary permits at its two vending machine towers in that state … citing late filing of documents, “improper issuance and verification of temporary Pennsylvania license plates in other states,” and other violations.”

As a result of this news, Carvana’s share price fell about 21% over the next two trading days, hurting investors.

Carvana’s Class Action…